Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9679072 | 0.74 | — | — | |
| SCHEMBL9679520 | 0.72 | — | — | |
| SCHEMBL11475404 | 0.68 | SMN1; SMN2 (0.45) | SMN1; SMN2 | |
| SCHEMBL9678054 | 0.67 | KMT2A (0.54) | — | |
| SCHEMBL10178353 | 0.67 | SMN1; SMN2 (0.37) | SMN1; SMN2 | |
| SCHEMBL13753310 | 0.66 | F2 (0.42) | SMN1; SMN2 | |
| SCHEMBL2728584 | 0.66 | KMT2A (0.44) | SMN1; SMN2 | |
| SCHEMBL13183831 | 0.65 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL13392622 | 0.64 | SMN1; SMN2 (0.35) | SMN1; SMN2 | |
| SCHEMBL10178055 | 0.64 | SMN1; SMN2 (0.35) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4996219-A | Antibody inhibitors | BOEHRINGER MANNHEIM GMBH (DE) | 1991-02-26 | — | — | US | claimed |
| EP-0373542-B1 | IMIDAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1992-06-17 | — | — | EP | disclosed |
| US-4996219-A | Antibody inhibitors | BOEHRINGER MANNHEIM GMBH (DE) | 1991-02-26 | — | — | US | disclosed |
| EP-0373542-A1 | Imidazoline derivatives, process for their preparation and medicaments containing them | Roche Diagnostics GmbH (DE) | 1990-06-20 | — | — | EP | disclosed |